Skip to main content

Tango Therapeutics, Inc 10-K for FY2023

Tango Therapeutics, Inc. (TNGX)

10-K 2024-03-18 For: 2023-12-31
View Original
Added on April 08, 2026

About this 10-K

Tango Therapeutics, Inc filed this 10-K on March 18, 2024, covering the fiscal year ended December 31, 2023 (FY2023).

Headline figures

Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$36.53M
up 46.9% from $24.86M a year earlier
Net loss
$101.74M
compared with a net loss of $108.18M a year earlier
Diluted EPS
-$1.08
compared with -$1.23 a year earlier